Cite

HARVARD Citation

    Tremblay, D. et al. (2020). Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm. Leukemia research. p. . [Online]. 
  
Back to record